corticosterone has been researched along with Psychoses, Drug in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Reynolds, AR | 1 |
Saunders, MA | 1 |
Brewton, HW | 1 |
Winchester, SR | 1 |
Elgumati, IS | 1 |
Prendergast, MA | 1 |
Carey, RJ | 1 |
Pinheiro-Carrera, M | 1 |
Dai, H | 1 |
Tomaz, C | 1 |
Huston, JP | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
PT150 (Formerly ORG34517) as a Potential Treatment for Alcohol Dependence-Alcohol Interaction Study[NCT03548714] | Phase 1 | 10 participants (Actual) | Interventional | 2018-09-01 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 other studies available for corticosterone and Psychoses, Drug
Article | Year |
---|---|
Acute oral administration of the novel, competitive and selective glucocorticoid receptor antagonist ORG 34517 reduces the severity of ethanol withdrawal and related hypothalamic-pituitary-adrenal axis activation.
Topics: Administration, Oral; Alcohol Drinking; Alcoholism; Animals; Benzodioxoles; Corticosterone; Ethanol; | 2015 |
L-DOPA and psychosis: evidence for L-DOPA-induced increases in prefrontal cortex dopamine and in serum corticosterone.
Topics: Animals; Antiparkinson Agents; Corpus Striatum; Corticosterone; Dopamine; Homovanillic Acid; Levodop | 1995 |